The present invention pertains to implantable medical devices, and, more specifically, to tissue-penetrating fixation components thereof.
An implantable medical device, for the delivery of stimulation therapy and/or for diagnostic sensing, may include at least one tissue-penetrating fixation component configured to hold the device at an implant location.
With reference to
With further reference to
The aforementioned co-pending and commonly assigned U.S. patent application '690 discloses suitable embodiments of a fixation component having tine portions similar to tine portions 230, wherein the tine portions exhibit a suitable baseline performance, for example, in terms of a deployment force, an acute retraction force (for repositioning), atraumatic retraction, and acute and chronic fixation forces. Yet, there is still a need for new configurations of tine portions for implantable devices, like device 200, that may further enhance fixation.
Some embodiments of the present invention encompass implantable medical devices (e.g., cardiac pacemakers) and tissue-penetrating fixation components thereof, which include one or more tine portions configured for increased strain relief during the flexing thereof, either at initial implant (particularly in cases where the retraction of penetrated tines is necessary for repositioning the device), or when subject to cyclic loading during a chronic implant of the fixated device, for example, within a beating heart. These tine portions are, preferably, also configured to reduce the risk of tissue trauma during the retraction thereof from the tissue, for example, for repositioning. In certain embodiments, a tissue-penetrating fixation component for an implantable medical device includes a tine portion configured to mitigate the risk of compressing, for example, to the point of occlusion, blood vessels in proximity to the implant site, without sacrificing chronic fixation performance, and while maintaining adequate strain relief.
According to some embodiments, a tine portion of a tissue-penetrating component of an implantable medical device includes a hook segment and a distal segment terminated by a tissue-piercing tip. The hook segment, which is pre-set to extend along a curvature that encloses an angle of between 135 degrees and 270 degrees, from a proximal end thereof, in proximity to the base portion, to a distal end thereof, and which is elastically deformable from the pre-set curvature to an open position, tapers from a first width thereof, in proximity to the proximal end thereof, to a second width thereof, in proximity to the distal end thereof, the second width being less than the first width. The distal segment, which is pre-set to extend along a relatively straight line, approximately tangent to the distal end of the hook segment, from the distal end of the hook segment, is terminated by a tissue-piercing tip that, preferably, has a width that is greater than the second width of the hook segment. The first width of the hook segment may be approximately two to five times greater than the second width thereof, and the width of the tissue-piercing tip may be two to three times greater than the second width.
According to some embodiments, in which a length of the distal segment of the tine portion is relatively short, to mitigate the risk of vessel compression, the distal segment either extends approximately parallel to a longitudinal axis of the component/device, or away from the longitudinal axis, when the hook segment conforms to the pre-set curvature.
According to some embodiments, in which the tissue-penetrating component further includes a base portion, for example, in the form of a ring, that defines the aforementioned longitudinal axis and is configured to be fixedly attached to the implantable medical device, the tine portion further includes a proximal segment that extends between the hook segment and the base portion, wherein the proximal segment may extend from the base portion toward the longitudinal axis.
The following drawings are illustrative of particular embodiments of the present invention and therefore do not limit the scope of the invention. The drawings are not to scale (unless so stated) and are intended for use in conjunction with the explanations in the following detailed description. Embodiments will hereinafter be described in conjunction with the appended drawings wherein like numerals/letters denote like elements, and:
The following detailed description is exemplary in nature and is not intended to limit the scope, applicability, or configuration of the invention in any way. Rather, the following description provides practical examples, and those skilled in the art will recognize that some of the examples may have suitable alternatives.
With further reference to
Various embodiments of tine portions for fixation of an implantable medical device, for example, as described below, incorporate a tapered hook segment and/or a shorter distal segment, to address the above described cyclic loading and/or potential tissue trauma. The following embodiments have been configured with reference to prior art tine portions of tissue-penetrating fixation components for medical devices, such as those described in the aforementioned commonly assigned U.S. patent application '690 (generally corresponding to tine portion 230), in order to allow a similar fit of devices, like device 200, within a delivery catheter, for example, having the tine portions deformed into the open position within distal portion 310 of catheter 300, and to maintain suitable baseline performance, for example, in terms of a deployment force (e.g., no greater than approximately 1-2 Newtons for a fixation component having four tine portions), an acute retraction force, for repositioning (e.g., between approximately 3-4 Newtons for a fixation component having four tine portions), atraumatic retraction, and an adequate acute fixation force (e.g., greater than approximately 2.5 Newtons for a fixation component having four tine portions).
With reference to
According to some preferred embodiments, component 63 is manufactured by, first, laser cutting base portion 603 and tine portions 630, together, from a tube of superelastic and biocompatible metal (e.g., Nitinol), and then wrapping and holding each tine portion 630 about a mandrel for a heat setting process that pre-sets the illustrated curvature of each hook segment 631. Manufacturing methods such as these are known to those skilled in the art of forming Nitinol components. Although
Each of tine portions 930A-D may be one of a plurality, which are included in a tissue-penetrating component, and that extend from a base portion 903 of the component, wherein base portion 903 defines an axis 9 of the component, and may be similar to the above described base portions 603, 703 of components 63, 73.
With further reference to
Because a reduction in the length, and/or tapering for strain relief of tine portions, can, in some instances, hinder initial tine penetration upon deployment (e.g., according to the method described above in conjunction with
In order to provide more flexibility in selecting a suitable implant location for device 500, a length of distal segment 632 of each tine portion 630 is relatively short compared to that of distal segment 232 of tine portion 230, for example, between approximately 0.05 inch and approximately 0.1 inch. The shorter length can help to prevent perforation through the wall of a structure, for example, the heart, at some implant locations, and can reduce a probability for penetrated tine portions 530 to interfere with blood vessels, which interference, for example, may compromise coronary blood supply, as described above. However, with reference back to
According to the illustrated embodiment, legs 541 of end 540 are configured to bend in elastic deformation when distal arch 542 is pushed against tissue at a potential implant site, for example, as illustrated in
In the foregoing detailed description, the invention has been described with reference to specific embodiments. However, it may be appreciated that various modifications and changes can be made without departing from the scope of the invention as set forth in the appended claims.
This application is a Continuation of U.S. patent application Ser. No. 13/955,393, filed Jul. 31, 2013, the content of which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
721869 | Dunning | Mar 1903 | A |
3717151 | Collett | Feb 1973 | A |
3754555 | Schmitt | Aug 1973 | A |
3814104 | Irnich et al. | Jun 1974 | A |
3835864 | Rasor et al. | Sep 1974 | A |
3902501 | Citron et al. | Sep 1975 | A |
3943936 | Rasor | Mar 1976 | A |
3971364 | Fletcher et al. | Jul 1976 | A |
3976082 | Schmitt | Aug 1976 | A |
4103690 | Harris | Aug 1978 | A |
4112952 | Thomas et al. | Sep 1978 | A |
4269198 | Stokes | May 1981 | A |
4280512 | Karr | Jul 1981 | A |
4301815 | Doring | Nov 1981 | A |
4402328 | Doring | Sep 1983 | A |
4409994 | Doring | Oct 1983 | A |
4502492 | Bornzin | Mar 1985 | A |
4662382 | Sluetz et al. | May 1987 | A |
4898577 | Badger et al. | Feb 1990 | A |
4913164 | Greene et al. | Apr 1990 | A |
5003990 | Osypka | Apr 1991 | A |
5057114 | Wittich et al. | Oct 1991 | A |
5129749 | Sato | Jul 1992 | A |
5171233 | Amplatz et al. | Dec 1992 | A |
5193540 | Schulman et al. | Mar 1993 | A |
5257634 | Kroll | Nov 1993 | A |
5282845 | Bush et al. | Feb 1994 | A |
5300107 | Stokes et al. | Apr 1994 | A |
5318528 | Heaven et al. | Jun 1994 | A |
5336253 | Gordon et al. | Aug 1994 | A |
5405367 | Schulman et al. | Apr 1995 | A |
5405374 | Stein | Apr 1995 | A |
5411535 | Fujii et al. | May 1995 | A |
5425756 | Heil et al. | Jun 1995 | A |
5443492 | Stokes et al. | Aug 1995 | A |
5492119 | Abrams | Feb 1996 | A |
5522875 | Gates et al. | Jun 1996 | A |
5522876 | Rusink | Jun 1996 | A |
5545201 | Helland et al. | Aug 1996 | A |
5545206 | Carson | Aug 1996 | A |
5562723 | Rugland et al. | Oct 1996 | A |
5575814 | Giele et al. | Nov 1996 | A |
5578068 | Laske et al. | Nov 1996 | A |
5697936 | Shipko et al. | Dec 1997 | A |
5716390 | Li | Feb 1998 | A |
5716391 | Grandjean | Feb 1998 | A |
5755764 | Schroeppel | May 1998 | A |
5776178 | Pohndorf et al. | Jul 1998 | A |
5807399 | Laske et al. | Sep 1998 | A |
5837006 | Ocel et al. | Nov 1998 | A |
5837007 | Altman et al. | Nov 1998 | A |
5851226 | Skubitz et al. | Dec 1998 | A |
5871531 | Struble | Feb 1999 | A |
5908381 | Aznoian et al. | Jun 1999 | A |
5908447 | Schroeppel et al. | Jun 1999 | A |
6041258 | Cigaina et al. | Mar 2000 | A |
6055457 | Bonner | Apr 2000 | A |
6074401 | Gardnier et al. | Jun 2000 | A |
6078840 | Stokes | Jun 2000 | A |
6093177 | Javier et al. | Jul 2000 | A |
6129749 | Bartig et al. | Oct 2000 | A |
6132456 | Sommer et al. | Oct 2000 | A |
6181973 | Ceron et al. | Jan 2001 | B1 |
6188932 | Lindegren | Feb 2001 | B1 |
6240322 | Peterfeso et al. | May 2001 | B1 |
6251104 | Kesten et al. | Jun 2001 | B1 |
6290719 | Garberoglio | Sep 2001 | B1 |
6321124 | Cigaina | Nov 2001 | B1 |
6322548 | Payne et al. | Nov 2001 | B1 |
RE37463 | Altman | Dec 2001 | E |
6358256 | Reinhardt | Mar 2002 | B1 |
6363938 | Saadat et al. | Apr 2002 | B2 |
6381495 | Jenkins | Apr 2002 | B1 |
6381500 | Fischer, Sr. | Apr 2002 | B1 |
6408214 | Williams et al. | Jun 2002 | B1 |
6458145 | Ravenscroft et al. | Oct 2002 | B1 |
6477423 | Jenkins | Nov 2002 | B1 |
6500182 | Foster | Dec 2002 | B2 |
6510332 | Greenstein | Jan 2003 | B1 |
6510345 | Van Bentem | Jan 2003 | B1 |
6522915 | Ceballos et al. | Feb 2003 | B1 |
6572587 | Lerman et al. | Jun 2003 | B2 |
6582441 | He et al. | Jun 2003 | B1 |
6592581 | Bowe | Jul 2003 | B2 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6626915 | Leveillee | Sep 2003 | B2 |
6638268 | Niazi | Oct 2003 | B2 |
6684109 | Osypka | Jan 2004 | B1 |
6711443 | Osypka | Mar 2004 | B2 |
6738672 | Schulman et al. | May 2004 | B2 |
6743240 | Smith et al. | Jun 2004 | B2 |
6755812 | Peterson et al. | Jun 2004 | B2 |
6823217 | Rutten et al. | Nov 2004 | B2 |
6909920 | Lokhoff et al. | Jun 2005 | B2 |
6944507 | Froberg | Sep 2005 | B2 |
6953454 | Peterson et al. | Oct 2005 | B2 |
7027876 | Casavant et al. | Apr 2006 | B2 |
7082335 | Klein et al. | Jul 2006 | B2 |
7082336 | Ransbury et al. | Jul 2006 | B2 |
7085606 | Flach et al. | Aug 2006 | B2 |
7092765 | Geske et al. | Aug 2006 | B2 |
7092766 | Salys et al. | Aug 2006 | B1 |
7120504 | Osypka | Oct 2006 | B2 |
7130700 | Gardeski et al. | Oct 2006 | B2 |
7149587 | Wardle et al. | Dec 2006 | B2 |
7158838 | Seifert et al. | Jan 2007 | B2 |
7162310 | Doan | Jan 2007 | B2 |
7181288 | Rezai et al. | Feb 2007 | B1 |
7187982 | Seifert et al. | Mar 2007 | B2 |
7200437 | Nabutovsky et al. | Apr 2007 | B1 |
7212869 | Wahlstrom et al. | May 2007 | B2 |
7229415 | Schwartz | Jun 2007 | B2 |
7251532 | Hess et al. | Jul 2007 | B2 |
7289853 | Campbell et al. | Oct 2007 | B1 |
7313445 | McVenes et al. | Dec 2007 | B2 |
7326231 | Phillips et al. | Feb 2008 | B2 |
7328071 | Stehr et al. | Feb 2008 | B1 |
7331922 | Mohl | Feb 2008 | B2 |
7383091 | Chitre et al. | Jun 2008 | B1 |
7450999 | Karicherla et al. | Nov 2008 | B1 |
7462184 | Worley et al. | Dec 2008 | B2 |
7463933 | Wahlstrom et al. | Dec 2008 | B2 |
7499758 | Cates et al. | Mar 2009 | B2 |
7509169 | Eigler et al. | Mar 2009 | B2 |
7515971 | Doan | Apr 2009 | B1 |
7532939 | Sommer et al. | May 2009 | B2 |
7558631 | Cowan et al. | Jul 2009 | B2 |
7634319 | Schneider et al. | Dec 2009 | B2 |
7647109 | Hastings et al. | Jan 2010 | B2 |
7657325 | Williams | Feb 2010 | B2 |
7678128 | Boyle et al. | Mar 2010 | B2 |
7717899 | Bowe et al. | May 2010 | B2 |
7731655 | Smith et al. | Jun 2010 | B2 |
7734343 | Ransbury et al. | Jun 2010 | B2 |
7740640 | Ginn | Jun 2010 | B2 |
7785264 | Hettrick et al. | Aug 2010 | B2 |
7799037 | He et al. | Sep 2010 | B1 |
7801624 | Flannery et al. | Sep 2010 | B1 |
7835801 | Sundararajan et al. | Nov 2010 | B1 |
7840281 | Kveen et al. | Nov 2010 | B2 |
7840283 | Bush et al. | Nov 2010 | B1 |
7860580 | Falk et al. | Dec 2010 | B2 |
7875049 | Eversull et al. | Jan 2011 | B2 |
7890186 | Wardle et al. | Feb 2011 | B2 |
7904179 | Rutten et al. | Mar 2011 | B2 |
7920928 | Yang et al. | Apr 2011 | B1 |
7949395 | Kuzma | May 2011 | B2 |
7993351 | Worley et al. | Aug 2011 | B2 |
8010209 | Jacobson | Aug 2011 | B2 |
8012127 | Lieberman et al. | Sep 2011 | B2 |
8032219 | Neumann et al. | Oct 2011 | B2 |
8036757 | Worley | Oct 2011 | B2 |
8057486 | Hansen | Nov 2011 | B2 |
8082035 | Glukhovsky | Dec 2011 | B2 |
8103361 | Moser | Jan 2012 | B2 |
8108054 | Helland | Jan 2012 | B2 |
8142347 | Griego et al. | Mar 2012 | B2 |
8160722 | Rutten et al. | Apr 2012 | B2 |
8170690 | Morgan et al. | May 2012 | B2 |
8185213 | Kveen et al. | May 2012 | B2 |
8219213 | Sommer et al. | Jul 2012 | B2 |
8233994 | Sommer et al. | Jul 2012 | B2 |
8252019 | Fleming, III | Aug 2012 | B2 |
8262672 | Neidert et al. | Sep 2012 | B2 |
8295939 | Jacobson | Oct 2012 | B2 |
8313445 | Mishima et al. | Nov 2012 | B2 |
8352025 | Jacobson | Jan 2013 | B2 |
8352028 | Wenger | Jan 2013 | B2 |
8364277 | Glukhovsky | Jan 2013 | B2 |
8364280 | Marnfeldt et al. | Jan 2013 | B2 |
8406900 | Barlov et al. | Mar 2013 | B2 |
8406901 | Starkebaum et al. | Mar 2013 | B2 |
8418362 | Zerfas | Apr 2013 | B2 |
8428750 | Kolberg | Apr 2013 | B2 |
8452420 | Flach et al. | May 2013 | B2 |
8478431 | Griswold et al. | Jul 2013 | B2 |
8489189 | Tronnes | Jul 2013 | B2 |
8494650 | Glukhovsky et al. | Jul 2013 | B2 |
8504156 | Bonner et al. | Aug 2013 | B2 |
8518060 | Jelich et al. | Aug 2013 | B2 |
8527068 | Ostroff | Sep 2013 | B2 |
8532790 | Griswold | Sep 2013 | B2 |
8548605 | Ollivier | Oct 2013 | B2 |
8565897 | Regnier et al. | Oct 2013 | B2 |
8615310 | Khairkhahan et al. | Dec 2013 | B2 |
8634912 | Bornzin et al. | Jan 2014 | B2 |
8670842 | Bornzin et al. | Mar 2014 | B1 |
8700181 | Bornzin et al. | Apr 2014 | B2 |
8721587 | Berthiaume et al. | May 2014 | B2 |
8727996 | Allan et al. | May 2014 | B2 |
8738147 | Hastings et al. | May 2014 | B2 |
8755909 | Sommer et al. | Jun 2014 | B2 |
8758365 | Bonner et al. | Jun 2014 | B2 |
9119959 | Rys et al. | Sep 2015 | B2 |
9155882 | Grubac et al. | Oct 2015 | B2 |
9283381 | Grubac | Mar 2016 | B2 |
9414857 | Wood et al. | Aug 2016 | B2 |
9446248 | Sheldon et al. | Sep 2016 | B2 |
9526891 | Eggen et al. | Dec 2016 | B2 |
9539423 | Bonner et al. | Jan 2017 | B2 |
10071243 | Kuhn et al. | Sep 2018 | B2 |
10099050 | Chen et al. | Oct 2018 | B2 |
20020077556 | Schwartz | Jun 2002 | A1 |
20020095203 | Thompson et al. | Jul 2002 | A1 |
20030004537 | Boyle et al. | Jan 2003 | A1 |
20030233139 | Chitre et al. | Dec 2003 | A1 |
20040034401 | Dahlberg | Feb 2004 | A1 |
20040147973 | Hauser | Jul 2004 | A1 |
20040176797 | Opolski | Sep 2004 | A1 |
20040230280 | Cates | Nov 2004 | A1 |
20040249417 | Ransbury et al. | Dec 2004 | A1 |
20050090890 | Wu et al. | Apr 2005 | A1 |
20050267555 | Marnfeldt et al. | Dec 2005 | A1 |
20060085039 | Hastings et al. | Apr 2006 | A1 |
20060247753 | Wenger et al. | Nov 2006 | A1 |
20070043414 | Fifer et al. | Feb 2007 | A1 |
20070135883 | Drasler et al. | Jun 2007 | A1 |
20070150037 | Hastings et al. | Jun 2007 | A1 |
20070150038 | Hastings et al. | Jun 2007 | A1 |
20070233218 | Kolberg | Oct 2007 | A1 |
20070239248 | Hastings et al. | Oct 2007 | A1 |
20070255376 | Michels et al. | Nov 2007 | A1 |
20070276444 | Gelbart | Nov 2007 | A1 |
20070293904 | Gelbart | Dec 2007 | A1 |
20080021532 | Kveen et al. | Jan 2008 | A1 |
20080051863 | Schneider | Feb 2008 | A1 |
20090082827 | Kveen et al. | Mar 2009 | A1 |
20090082828 | Ostroff | Mar 2009 | A1 |
20090204170 | Hastings et al. | Aug 2009 | A1 |
20090281605 | Marnfeldt et al. | Nov 2009 | A1 |
20100131036 | Geistert et al. | May 2010 | A1 |
20100198288 | Ostroff | Aug 2010 | A1 |
20100211149 | Morgan et al. | Aug 2010 | A1 |
20110034939 | Kveen et al. | Feb 2011 | A1 |
20110054555 | Williams et al. | Mar 2011 | A1 |
20110112548 | Fifer et al. | May 2011 | A1 |
20110125163 | Rutten et al. | May 2011 | A1 |
20110190785 | Gerber et al. | Aug 2011 | A1 |
20110190786 | Gerber et al. | Aug 2011 | A1 |
20110208260 | Jacobson | Aug 2011 | A1 |
20110237967 | Moore et al. | Sep 2011 | A1 |
20110251660 | Griswold | Oct 2011 | A1 |
20110251661 | Fifer et al. | Oct 2011 | A1 |
20110251662 | Griswold et al. | Oct 2011 | A1 |
20110270339 | Murray, III et al. | Nov 2011 | A1 |
20110270340 | Pellegrini et al. | Nov 2011 | A1 |
20110282423 | Jacobson | Nov 2011 | A1 |
20110307043 | Ollivier | Dec 2011 | A1 |
20120078322 | Dal Molin et al. | Mar 2012 | A1 |
20120078336 | Helland | Mar 2012 | A1 |
20120095539 | Khairkhahan et al. | Apr 2012 | A1 |
20120108986 | Beasley | May 2012 | A1 |
20120109002 | Mothilal et al. | May 2012 | A1 |
20120109079 | Asleson et al. | May 2012 | A1 |
20120109148 | Bonner et al. | May 2012 | A1 |
20120109149 | Bonner et al. | May 2012 | A1 |
20120116489 | Khairkhahan et al. | May 2012 | A1 |
20120158111 | Khairkhahan et al. | Jun 2012 | A1 |
20120165827 | Khairkhahan et al. | Jun 2012 | A1 |
20120172690 | Anderson et al. | Jul 2012 | A1 |
20120172891 | Lee | Jul 2012 | A1 |
20120172892 | Grubac et al. | Jul 2012 | A1 |
20120197373 | Khairkhahan et al. | Aug 2012 | A1 |
20120232565 | Kveen et al. | Sep 2012 | A1 |
20120271134 | Allan et al. | Oct 2012 | A1 |
20120330392 | Regnier et al. | Dec 2012 | A1 |
20130006261 | Lampropoulos et al. | Jan 2013 | A1 |
20130006262 | Lampropoulos et al. | Jan 2013 | A1 |
20130012925 | Berthiaume et al. | Jan 2013 | A1 |
20130035636 | Beasley et al. | Feb 2013 | A1 |
20130035748 | Bonner et al. | Feb 2013 | A1 |
20130053921 | Bonner et al. | Feb 2013 | A1 |
20130079798 | Tran et al. | Mar 2013 | A1 |
20130079861 | Reinert et al. | Mar 2013 | A1 |
20130103047 | Steingisser et al. | Apr 2013 | A1 |
20130103049 | Bonde | Apr 2013 | A1 |
20130110127 | Bornzin et al. | May 2013 | A1 |
20130110219 | Bornzin et al. | May 2013 | A1 |
20130116738 | Samade et al. | May 2013 | A1 |
20130116740 | Bornzin et al. | May 2013 | A1 |
20130116741 | Bornzin et al. | May 2013 | A1 |
20130123875 | Varady et al. | May 2013 | A1 |
20130131591 | Berthiaume et al. | May 2013 | A1 |
20130131693 | Berthiaume et al. | May 2013 | A1 |
20130233345 | Baarsch et al. | Sep 2013 | A1 |
20130253342 | Griswold et al. | Sep 2013 | A1 |
20130253343 | Waldhauser et al. | Sep 2013 | A1 |
20130253344 | Griswold et al. | Sep 2013 | A1 |
20130253345 | Griswold et al. | Sep 2013 | A1 |
20130253346 | Griswold et al. | Sep 2013 | A1 |
20130253347 | Griswold et al. | Sep 2013 | A1 |
20130296957 | Tronnes | Nov 2013 | A1 |
20140058494 | Ostroff et al. | Feb 2014 | A1 |
20140074114 | Khairkhahan et al. | Mar 2014 | A1 |
20140107723 | Hou et al. | Apr 2014 | A1 |
20140148815 | Wenzel et al. | May 2014 | A1 |
20140180306 | Grubac et al. | Jun 2014 | A1 |
20150039069 | Rys et al. | Feb 2015 | A1 |
20150039070 | Kuhn et al. | Feb 2015 | A1 |
20150039071 | Grubac et al. | Feb 2015 | A1 |
20150051616 | Hassl et al. | Feb 2015 | A1 |
20150051682 | Schmidt et al. | Feb 2015 | A1 |
20150094668 | Wood et al. | Apr 2015 | A1 |
20150352353 | Rys et al. | Dec 2015 | A1 |
20160001068 | Grubac et al. | Jan 2016 | A1 |
20160059002 | Grubac et al. | Mar 2016 | A1 |
20160094668 | Chang et al. | Mar 2016 | A1 |
20170209688 | Drake et al. | Jul 2017 | A1 |
Number | Date | Country |
---|---|---|
1003904 | Jan 1977 | CA |
1882370 | Dec 2006 | CN |
1882370 | Dec 2006 | CN |
2053919 | May 1972 | DE |
0212955 | Mar 1987 | EP |
779080 | May 2003 | EP |
H02-88666 | Jul 1990 | JP |
05245215 | Sep 1993 | JP |
2011151104 | Jun 2013 | RU |
WO9520993 | Aug 1995 | WO |
WO0102053 | Jan 2001 | WO |
03032807 | Apr 2003 | WO |
2004028348 | Apr 2004 | WO |
2009039400 | Mar 2009 | WO |
2009042295 | Apr 2009 | WO |
2010131157 | Nov 2010 | WO |
2012092067 | Jul 2012 | WO |
2012092074 | Jul 2012 | WO |
WO12135530 | Oct 2012 | WO |
2014006471 | Jan 2014 | WO |
Entry |
---|
Chinese Office Action dated Sep. 6, 2016, Application No. 201480038011.7, English transaltion, 4 pages. |
(PCT/US2014/047962)PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, dated Oct. 10, 2014, 11 pages. |
International Search Report from Written Opinion from International Application No. PCT/US2014/047962, dated Feb. 5, 2015, 6 pp. |
International Preliminary Report on Patentability from International Application No. PCT/US2014/047962, dated Feb. 2, 2016, 11 pp. |
Chinese Office Action dated Sep. 6, 2016, Application No. 201480038011.7 Chinese translation, 9 pages. |
Chinese Office Action dated Sep. 6, 2016, Application No. 201480038011.7 English translation, 4 pages. |
U.S. Appl. No. 16/158,724, filed by Xin Chen et al., filed Oct. 12, 2018. |
Prosecution History from U.S. Appl. No. 13/955,393, dated from Nov. 26, 2014 through Aug. 10, 2018, 104 pp. |
Notice of Allowance from U.S. Appl. No. 15/410,161, dated Jun. 13, 2018, 5 pp. |
“Homer Mammalok Gold,” accessed on or about Jan. 19, 2017, accessed from http://www.mana-tech.com/factsheets/HomerMammalok.pdf, 1 pp. |
Medtronic model Selectrsuretm™ 3830 manual, 2013, accessed on or about Jan. 19, 2017, 20 pp. |
Merriam-Webster Definition of “Compound Curve,” accessed on Apr. 25, 2017, https://merriam-webster.com/dictionary/compound%20curve, 4 pp. |
Spickler, et al., “Totally Self-Contained Intracardiac Pacemaker,” J. Electrocardiology, vol. 3, Nos. 3 & 4, pp. 325-331, 1970. (Applicant points out, in accordance with MPEP 609.04(a), that the year of publication, 1970 is sufficiently earlier than the effective U.S. filing date, so that the particular month of publication is not in issue.). |
Prosecution History from U.S. Appl. No. 15/410,085, dated from Nov. 2, 2018 through Feb. 7, 2019, 17 pp. |
Notice of Allowance from U.S. Appl. No. 15/410,085, dated Jun. 26, 2019, 8 pp. |
Prosecution History from U.S. Appl. No. 16/158,724, dated from Oct. 12, 2018 to Nov. 29, 2018, 38 pp. |
Response to Office Action dated Feb. 7, 2019, from U.S. Appl. No. 15/410,085, filed May 6, 2019, 13 pp. |
Number | Date | Country | |
---|---|---|---|
20190009078 A1 | Jan 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13955393 | Jul 2013 | US |
Child | 16128270 | US |